Diagnosis of primary hyperparathyroidism

被引:0
作者
Delgado-Gomez, Manuel [1 ]
De La Hoz-Guerra, Sonsoles [2 ]
Garcia-Duque, Maria [1 ]
Vega-Blanco, Maria [1 ]
Blanco-Urbaneja, Irune [1 ]
机构
[1] Complejo Asistencial Univ Salamanca, Serv Endocrinol & Nutr, Salamanca, Spain
[2] Atenc Primaria, Area Salud Bejar, Salamanca, Spain
关键词
primary hyperparathyroidism; parathyroid hormone; PTH; hypercalcemia; hypercalciuria; vitamin D; HYPERCALCEMIA; MANAGEMENT; GUIDELINES; STATEMENT;
D O I
10.14201/orl.21428
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Introduction and objective: To describe the etiopathogenesis and differential diagnosis between primary hyperparathyroidism and other causes of hypercalcemia. Synthesis: Primary hyperparathyroidism (PHPT) is a common endocrine disease, which is conventionally defined as the existence of hypercalcemia in the presence of elevated levels of parathyroid hormone (PTH). Although the most common form of presentation nowadays is as asymptomatic hypercalcemia, the high morbidity associated with this pathology requires that an early and precise diagnosis be made, both of the etiology and its complications, in order to carry out an adequate management of the affected patients.
引用
收藏
页码:347 / 359
页数:13
相关论文
共 24 条
  • [1] Primary Hyperparathyroidism
    Bilezikian, John P.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (11) : 3993 - 4004
  • [2] Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop
    Bilezikian, John P.
    Brandi, Maria Luisa
    Eastell, Richard
    Silverberg, Shonni J.
    Udelsman, Robert
    Marcocci, Claudio
    Potts, John T., Jr.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (10) : 3561 - 3569
  • [3] Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International Workshop
    Bilezikian, John P.
    Khan, Aliya A.
    Potts, John T., Jr.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (02) : 335 - 339
  • [4] Increase of PTH in post-menopausal osteoporosis
    Cerda, D.
    Peris, P.
    Monegal, A.
    Albaladejo, C.
    Martinez de Osaba, M. J.
    Suris, X.
    Guanabens, N.
    [J]. REVISTA CLINICA ESPANOLA, 2011, 211 (07): : 338 - 343
  • [5] Familial hypocalciuric hypercalcaemia: a review
    Christensen, Signe E.
    Nissen, Peter H.
    Vestergaard, Peter
    Mosekilde, Leif
    [J]. CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2011, 18 (06) : 359 - 370
  • [6] EVIDENCE FOR SECONDARY HYPERPARATHYROIDISM IN IDIOPATHIC HYPERCALCIURIA
    COE, FL
    CANTERBURY, JM
    FIRPO, JJ
    REISS, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (01) : 134 - 142
  • [7] Normocalcemic Primary Hyperparathyroidism
    Cusano, Natalie E.
    Silverberg, Shonni J.
    Bilezikian, John P.
    [J]. JOURNAL OF CLINICAL DENSITOMETRY, 2013, 16 (01) : 33 - 39
  • [8] Renal stone disease, elevated iPTH level and normocalcemia
    Dimkovic N.B.
    Wallele A.A.
    Oreopoulos D.G.
    [J]. International Urology and Nephrology, 2002, 34 (1) : 135 - 141
  • [9] Thiazide-Associated Hypercalcemia: Incidence and Association With Primary Hyperparathyroidism Over Two Decades
    Griebeler, Marcio L.
    Kearns, Ann E.
    Ryu, Euijung
    Thapa, Prabin
    Hathcock, Matthew A.
    Melton, L. Joseph, III
    Wermers, Robert A.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (03) : 1166 - 1173
  • [10] The effects of age and gender on parathyroid hormone dynamics
    Haden, ST
    Brown, EM
    Hurwitz, S
    Scott, J
    El-Hajj Fuleihan, G
    [J]. CLINICAL ENDOCRINOLOGY, 2000, 52 (03) : 329 - 338